Search

Your search keyword '"Kakehi, Yoshiyuki"' showing total 1,027 results
Start Over Author "Kakehi, Yoshiyuki"
1,027 results on '"Kakehi, Yoshiyuki"'

3. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

Author

Tohi, Yoichiro, Ishikawa, Ryou, Kato, Takuma, Miyakawa, Jimpei, Matsumoto, Ryuji, Mori, Keiichiro, Mitsuzuka, Koji, Inokuchi, Junichi, Matsumura, Masafumi, Shiga, Kenichiro, Naito, Hirohito, Kohjimoto, Yasuo, Kawamura, Norihiko, Inoue, Masaharu, Kinoshita, Hidefumi, Hashimoto, Kohei, Goto, Keisuke, Haba, Reiji, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2023
Full Text
View/download PDF

5. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

Author

Van Hemelrijck, Mieke, Ji, Xi, Helleman, Jozien, Roobol, Monique J, van der Linden, Wim, Nieboer, Daan, Bangma, Chris H, Frydenberg, Mark, Rannikko, Antti, Lee, Lui S, Gnanapragasam, Vincent J, Kattan, Mike W, Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M, Gnanapragasam, Vincent, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, Obbink, Henk, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Zhang, Liying, Santa Olalla, Aida, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, La Pointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, and Bruinsma, Sophie

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Prostate Cancer, Aging, Prevention, Urologic Diseases, Cancer, Good Health and Well Being, Aged, Asia, Australia, Biopsy, Cause of Death, Clinical Decision-Making, Databases, Factual, Disease Progression, Early Detection of Cancer, Europe, Humans, Kallikreins, Male, Middle Aged, North America, Patient Dropouts, Predictive Value of Tests, Prostate-Specific Antigen, Prostatic Neoplasms, Risk Assessment, Risk Factors, Time Factors, Watchful Waiting, Prostate cancer, Active surveillance, Discontinuation, Worldwide, Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium, Urology & Nephrology, Clinical sciences
Abstract

BackgroundCareful assessment of the reasons for discontinuation of active surveillance (AS) is required for men with prostate cancer (PCa).ObjectiveUsing Movember's Global Action Plan Prostate Cancer Active Surveillance initiative (GAP3) database, we report on reasons for AS discontinuation.Design, setting, and participantsWe compared data from 10296 men on AS from 21 centres across 12 countries.Outcome measurements and statistical analysisCumulative incidence methods were used to estimate the cumulative incidence rates of AS discontinuation.Results and limitationsDuring 5-yr follow-up, 27.5% (95% confidence interval [CI]: 26.4-28.6%) men showed signs of disease progression, 12.8% (95% CI: 12.0-13.6%) converted to active treatment without evidence of progression, 1.7% (95% CI: 1.5-2.0%) continued to watchful waiting, and 1.7% (95% CI: 1.4-2.1%) died from other causes. Of the 7049 men who remained on AS, 2339 had follow-up for >5yr, 4561 had follow-up for

Published
2019

6. Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN

Author

Kato, Takuma, Hirama, Hiromi, Mitsuzuka, Koji, Maruyama, Satoru, Sasaki, Hiroshi, Saito, Toshihiro, Matsumoto, Ryuji, Sakamoto, Shinichi, Sakai, Yasuyuki, Fukuhara, Hiroshi, Naya, Yukio, Tsukino, Hiromasa, Hara, Isao, Ogawa, Osamu, Hashine, Katsuyoshi, Fumimasa, Fukuta, Yokomizo, Akira, Tohi, Yoichiro, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

8. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

Author

Sugimoto, Mikio, Kato, Takuma, Tohi, Yoichiro, Shimizu, Yosuke, Matsumoto, Ryuji, Inoue, Takahiro, Takezawa, Yutaka, Masui, Kimihiko, Sasaki, Hiroshi, Hirama, Hiromi, Saito, Shiro, Egawa, Shin, Kamoto, Toshiyuki, Teramukai, Satoshi, Kojima, Shinsuke, Kikuchi, Takashi, and Kakehi, Yoshiyuki

Published
2022
Full Text
View/download PDF

9. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Nakamura, Masaki, Matsumoto, Ryuji, Sasaki, Hiroshi, Mitsuzuka, Koji, Inokuchi, Junichi, Hashine, Katsuyoshi, Yokomizo, Akira, Naito, Hirohito, Hara, Isao, Kawamura, Norihiko, Inoue, Masaharu, Fukuhara, Hiroshi, Maruyama, Satoru, Sakamoto, Shinichi, Saito, Toshihiro, Egawa, Shin, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

11. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

Author

Hirama, Hiromi, Sugimoto, Mikio, Miyatake, Nobuyuki, Kato, Takuma, Venderbos, Lionne D. F., Remmers, Sebastiaan, Shiga, Kenichiro, Yokomizo, Akira, Mitsuzuka, Koji, Matsumoto, Ryuji, Osawa, Takahiro, Abe, Takashige, Sasaki, Hiroshi, Egawa, Shin, Ninomiya, Iku, Hashine, Katsuyoshi, Roobol, Monique J., and Kakehi, Yoshiyuki

Published
2021
Full Text
View/download PDF

12. Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS‐JAPAN).

Author

Kato, Takuma, Matsumoto, Ryuji, Yokomizo, Akira, Tohi, Yoichiro, Fukuhara, Hiroshi, Fujii, Yoichi, Mori, Keiichiro, Sato, Takuma, Inokuchi, Junichi, Hashine, Katsuyoshi, Sakamoto, Shinichi, Kinoshita, Hidefumi, Inoue, Koji, Tanikawa, Toshiki, Utsumi, Takanobu, Goto, Takayuki, Hara, Isao, Okuno, Hiroshi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Subjects
TUMOR antigens, PROSTATE cancer patients, MAGNETIC resonance imaging, WATCHFUL waiting, JAPANESE people
Abstract

Objective: To report the outcomes of repeat biopsies, metastasis and survival in the Prostate Cancer Research International: Active Surveillance (PRIAS)‐JAPAN study, a prospective observational study for Japanese patients, initiated in 2010. Patients and Methods: At the beginning, inclusion criteria were initially low‐risk patients, prostate‐specific antigen (PSA) density (PSAD) <0.2, and ≤2 positive biopsy cores. As from 2014, GS3+4 has also been allowed for patients aged 70 years and over. Since January 2021, the age limit for Gleason score (GS) 3 + 4 cases was removed, and eligibility criteria were expanded to PSA ≤20 ng/mL, PSAD <0.25 nd/mL/cc, unlimited number of positive GS 3 + 3 cores, and positive results for fewer than half of the total number of cores for GS 3 + 4 cases if magnetic resonance imaging fusion biopsy was performed at study enrolment or subsequent follow‐up. For patients eligible for active surveillance, PSA tests were performed every 3 months, rectal examination every 6 months, and biopsies at 1, 4, 7 and 10 years, followed by every 5 years thereafter. Patients with confirmed pathological reclassification were recommended for secondary treatments. Results: As of February 2024, 1302 patients were enrolled in AS; 1274 (98%) met the eligibility criteria. The median (interquartile range) age, PSA level, PSAD, and number of positive cores were 69 (64–73) years, 5.3 (4.5–6.6) ng/mL, 0.15 (0.12–0.17) ng/mL, and 1 (1–2), respectively. The clinical stage was T1c in 1089 patients (86%) and T2 in 185 (15%). The rates of acceptance by patients for the first, second, third and fourth re‐biopsies were 83%, 64%, 41% and 22%, respectively. The pathological reclassification rates for the first, second, third and fourth re‐biopsies were 29%, 30%, 35% and 25%, respectively. The 1‐, 5‐ and 10‐year persistence rates were 77%, 45% and 23%, respectively. Six patients developed metastasis, and one patient died from prostate cancer. Conclusion: Pathological reclassification was observed in approximately 30% of the patients during biopsy; however, biopsy acceptance rates decreased over time. Although metastasis occurred in six patients, only one death from prostate cancer was recorded. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†

Author

Yokomizo, Akira, Wakabayashi, Masashi, Satoh, Takefumi, Hashine, Katsuyoshi, Inoue, Takahiro, Fujimoto, Kiyohide, Egawa, Shin, Habuchi, Tomonori, Kawashima, Kiyotaka, Ishizuka, Osamu, Shinohara, Nobuo, Sugimoto, Mikio, Yoshino, Yasushi, Nihei, Keiji, Fukuda, Haruhiko, Tobisu, Ken-ichi, Kakehi, Yoshiyuki, and Naito, Seiji

Published
2020
Full Text
View/download PDF

15. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Frydenberg, Mark, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, Obbink, Henk, van der Linden, Wim, Hulsen, Tim, Jonge, Cees de, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Nieboer, Daan, Zhang, Liying, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, Bruinsma, Sophie, Helleman, Jozien, Kalapara, Arveen A., Verbeek, Jan F.M., Lee, Lui Shiong, Bangma, Chris H., Steyerberg, Ewout W., Harkin, Tim, and Roobol, Monique J.

Published
2020
Full Text
View/download PDF

16. Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents

Author

Uemura, Hirotsugu, Masumori, Naoya, Takahashi, Shunji, Hosono, Makoto, Kinuya, Seigo, Sunaya, Toshiyuki, Horio, Tomoyo, Okayama, Yutaka, and Kakehi, Yoshiyuki

Published
2021
Full Text
View/download PDF

17. The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Matsumoto, Ryuji, Shinohara, Nobuo, Shiga, Kenichiro, Yokomizo, Akira, Nakamura, Masaki, Kume, Haruki, Mitsuzuka, Koji, Sasaki, Hiroshi, Egawa, Shin, Matsumura, Masafumi, Hashine, Katsuyoshi, Inokuchi, Junichi, Eto, Masatoshi, Baba, Haruki, Ichikawa, Tomohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2020
Full Text
View/download PDF

18. A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study

Author

Matsubara, Nobuaki, Kimura, Go, Uemura, Hiroji, Uemura, Hirotsugu, Nakamura, Motonobu, Nagamori, Satoshi, Mizokami, Atsushi, Kikukawa, Hiroaki, Hosono, Makoto, Kinuya, Seigo, Krissel, Heiko, Siegel, Jonathan, and Kakehi, Yoshiyuki

Published
2020
Full Text
View/download PDF

20. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Rannikko, Antti, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Frydenberg, Mark, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, van der Linden, Wim, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Zhang, Liying, Nieboer, Daan, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Han Lin, Catherine, Hirama, Hiromi, Suk Lee, Kwang, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, Bruinsma, Sophie, Helleman, Jozien, Drost, Frank-Jan H., Morgan, Todd M., Carroll, Peter R., and Roobol, Monique J.

Published
2019
Full Text
View/download PDF

21. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Smith, Matthew, Parker, Chris, Saad, Fred, Miller, Kurt, Tombal, Bertrand, Ng, Quan Sing, Boegemann, Martin, Matveev, Vsevolod, Piulats, Josep Maria, Zucca, Luis Eduardo, Karyakin, Oleg, Kimura, Go, Matsubara, Nobuaki, Nahas, William Carlos, Nolè, Franco, Rosenbaum, Eli, Heidenreich, Axel, Kakehi, Yoshiyuki, Zhang, Amily, Krissel, Heiko, Teufel, Michael, Shen, Junwu, Wagner, Volker, and Higano, Celestia

Published
2019
Full Text
View/download PDF

22. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Lui Shiong, Lee, Frydenberg, Mark, Kakehi, Yoshiyuki, Ha Chung, Byung, van der Kwast, Theo, Obbink, Henk, van der Linden, Wim, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Nieboer, Daan, Zhang, Liying, Santa Olalla, Aida, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, La Pointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Han Lin, Catherine, Hirama, Hiromi, Suk Lee, Kwang, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, Bruinsma, Sophie, Helleman, Jozien, Ji, Xi, Roobol, Monique J., Bangma, Chris H., Lee, Lui S., Gnanapragasam, Vincent J., and Kattan, Mike W.

Published
2019
Full Text
View/download PDF

24. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Yokomizo, Akira, Mitsuzuka, Koji, Tomida, Ryotaro, Inokuchi, Junichi, Matsumoto, Ryuji, Saito, Toshihiro, Sasaki, Hiroshi, Inoue, Koji, Kinoshita, Hidefumi, Fukuhara, Hiroshi, Maruyama, Satoru, Sakamoto, Shinichi, Tanikawa, Toshiki, Egawa, Shin, Ichikura, Haruhiko, Abe, Takashige, Nakamura, Masaki, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

25. Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Matsumoto, Ryuji, Shinohara, Nobuo, Shiga, Kenichiro, Yokomizo, Akira, Nakamura, Masaki, Kume, Haruki, Mitsuzuka, Koji, Sasaki, Hiroshi, Egawa, Shin, Matsumura, Masafumi, Hashine, Katsuyoshi, Inokuchi, Junichi, Eto, Masatoshi, Baba, Haruki, Ichikawa, Tomohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

30. Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases

Author

Takahashi, Shunji, Kinuya, Seigo, Nonomura, Norio, Shinohara, Nobuo, Suzuki, Kazuhiro, Suzuki, Hiroyoshi, Nakamura, Katsumasa, Satoh, Takefumi, Tateishi, Ukihide, Yoneda, Toshiyuki, Horikoshi, Hiroyuki, Igawa, Tsukasa, Kamai, Takao, Koizumi, Mitsuru, Kosaka, Takeo, Matsubara, Nobuaki, Miyake, Hideaki, Mizokami, Atsushi, Mizowaki, Takashi, Nakamura, Naoki, Nozawa, Masahiro, Takahashi, Takeo, Uemura, Hiroji, Uemura, Motohide, Yokomizo, Akira, Yoshimura, Mana, and Kakehi, Yoshiyuki

Published
2018
Full Text
View/download PDF

33. The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

Author

Terada, Naoki, Kamoto, Toshiyuki, Tsukino, Hiromasa, Mukai, Shoichiro, Akamatsu, Shusuke, Inoue, Takahiro, Ogawa, Osamu, Narita, Shintaro, Habuchi, Tomonori, Yamashita, Shinichi, Mitsuzuka, Koji, Arai, Yoichi, Kandori, Shuya, Kojima, Takahiro, Nishiyama, Hiroyuki, Kawamura, Yoshiaki, Shimizu, Yuki, Terachi, Toshiro, Sugi, Motohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Yamada, Yusuke, Yamamoto, Shingo, Hirama, Hiromi, Sugimoto, Mikio, Kakehi, Yoshiyuki, Sakurai, Toshihiko, and Tsuchiya, Norihiko

Published
2019
Full Text
View/download PDF

35. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A

Author

Inokuchi, Junichi, Kuroiwa, Kentaro, Kakehi, Yoshiyuki, Sugimoto, Mikio, Tanigawa, Toshiki, Fujimoto, Hiroyuki, Gotoh, Momokazu, Masumori, Naoya, Ogawa, Osamu, Eto, Masatoshi, Ohyama, Chikara, Yamaguchi, Akito, Matsuyama, Hideyasu, Ichikawa, Tomohiko, Asano, Tomohiko, Mizusawa, Junki, Eba, Junko, and Naito, Seiji

Published
2017
Full Text
View/download PDF

36. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

Author

Tohi, Yoichiro, primary, Ishikawa, Ryou, additional, Kato, Takuma, additional, Miyakawa, Jimpei, additional, Matsumoto, Ryuji, additional, Mori, Keiichiro, additional, Mitsuzuka, Koji, additional, Inokuchi, Junichi, additional, Matsumura, Masafumi, additional, Shiga, Kenichiro, additional, Naito, Hirohito, additional, Kohjimoto, Yasuo, additional, Kawamura, Norihiko, additional, Inoue, Masaharu, additional, Kinoshita, Hidefumi, additional, Hashimoto, Kohei, additional, Goto, Keisuke, additional, Haba, Reiji, additional, Kakehi, Yoshiyuki, additional, and Sugimoto, Mikio, additional

Published
2022
Full Text
View/download PDF

38. President messages

Author

Nantachit, Niwes, Ay, Chyung, and Kakehi, Yoshiyuki

Abstract

application/pdf

Published
2022

39. Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study

Author

Togo, Yoshikazu, Yamamoto, Shingo, Tanaka, Shiro, Kanematsu, Akihiro, Ogawa, Osamu, Miyazato, Minoru, Saito, Hideo, Arai, Yoichi, Hoshi, Akio, Terachi, Toshiro, Fukui, Katsuya, Kinoshita, Hidefumi, Matsuda, Tadashi, Yamashita, Motoki, Kakehi, Yoshiyuki, Tsuchihashi, Kazunari, Sasaki, Miharu, Ishitoya, Satoshi, Onishi, Hiroyuki, Takahashi, Akira, Ogura, Keiji, Mishina, Mutsuki, Okuno, Hiroshi, Oida, Tomoyuki, Horii, Yasuki, Hamada, Akihiro, Okasyo, Kosuke, Okumura, Kazuhiro, Iwamura, Hiroshi, Nishimura, Kazuo, Manabe, Yumi, Hashimura, Takayuki, Horikoshi, Mikito, Mishima, Takao, Okada, Takuya, Sumiyoshi, Takayuki, Kawakita, Mutsushi, Kanamaru, Sojun, Ito, Noriyuki, Aoki, Dai, Kawaguchi, Risaku, Yamada, Yusuke, Kokura, Koji, Nagai, Jun, Kondoh, Nobuyuki, Kajio, Keisuke, and Yoshimoto, Tetsuro

Published
2013
Full Text
View/download PDF

44. Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer

Author

Nozawa, Masahiro, Mukai, Hirofumi, Takahashi, Shunji, Uemura, Hiroji, Kosaka, Takeo, Onozawa, Yusuke, Miyazaki, Jun, Suzuki, Kazuhiro, Okihara, Koji, Arai, Yoichi, Kamba, Tomomi, Kato, Masashi, Nakai, Yasutomo, Furuse, Hiroshi, Kume, Haruki, Ide, Hisamitsu, Kitamura, Hiroshi, Yokomizo, Akira, Kimura, Takahiro, Tomita, Yoshihiko, Ohno, Keiji, and Kakehi, Yoshiyuki

Published
2015
Full Text
View/download PDF

46. Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study

Author

Kato, Takuma, primary, Yokomizo, Akira, additional, Matsumoto, Ryuji, additional, Tohi, Yoichiro, additional, Miyakawa, Jimpei, additional, Mitsuzuka, Koji, additional, Sasaki, Hiroshi, additional, Inokuchi, Junichi, additional, Matsumura, Masafumi, additional, Sakamoto, Shinichi, additional, Kinoshita, Hidefumi, additional, Fukuhara, Hiroshi, additional, Kamiya, Naoto, additional, Kimura, Ryu, additional, Nitta, Masahiro, additional, Okuno, Hiroshi, additional, Akakura, Koichiro, additional, Kakehi, Yoshiyuki, additional, and Sugimoto, Mikio, additional

Published
2022
Full Text
View/download PDF

48. Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study

Author

Tohi, Yoichiro, primary, Kato, Takuma, additional, Miyakawa, Jimpei, additional, Matsumoto, Ryuji, additional, Sasaki, Hiroshi, additional, Mitsuzuka, Koji, additional, Inokuchi, Junichi, additional, Matsumura, Masafumi, additional, Yokomizo, Akira, additional, Kinoshita, Hidefumi, additional, Hara, Isao, additional, Kawamura, Norihiko, additional, Hashimoto, Kohei, additional, Inoue, Masaharu, additional, Teishima, Jun, additional, Kanno, Hidenori, additional, Fukuhara, Hiroshi, additional, Maruyama, Satoru, additional, Sakamoto, Shinichi, additional, Saito, Toshihiro, additional, Kakehi, Yoshiyuki, additional, and Sugimoto, Mikio, additional

Published
2022
Full Text
View/download PDF

49. 10 years since establishment of International Office

Author

Tokuda, Masaaki, Kakehi, Yoshiyuki, Uemura, Yukako, Imai, Yoshiro, Kawamura, Osamu, Sakurai, Yoshiki, Mizuno, Koichi, and Wada, Kenji

Abstract

application/pdf, 【序文】インターナショナルオフィス設立10年を経て, 【寄稿】グローバル教育の意義とインターナショナルオフィスへの期待, インターナショナルオフィスのあゆみ10年 年表, インターナショナルオフィスのあゆみ10年—中規模地方国立大学の国際化—, インターナショナルオフィスの果たすべき役割像、インターナショナルオフィスに期待すること, 評価できる点と改善の余地がある点, インターナショナルオフィス10周年に当たって, インターナショナルオフィスの10年とこれから, インターナショナルオフィスへの感謝と期待

Published
2020

50. Additional file 2 of Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

Author

Sugimoto, Mikio, Kato, Takuma, Tohi, Yoichiro, Shimizu, Yosuke, Matsumoto, Ryuji, Inoue, Takahiro, Takezawa, Yutaka, Masui, Kimihiko, Sasaki, Hiroshi, Hirama, Hiromi, Saito, Shiro, Egawa, Shin, Kamoto, Toshiyuki, Teramukai, Satoshi, Kojima, Shinsuke, Kikuchi, Takashi, and Kakehi, Yoshiyuki

Abstract

Additional file 2. Supplementary table. Summary of adverse events.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results